SomaLogic boasts industry-leading reliability metrics that include sensitivity, specificity, and reproducibility. Learn More
The CU Boulder Connection
Professor Larry Gold (MCDB) founded SomaLogic, which pioneered the development of proteomics diagnostics and assays based on Gold’s SELEX technology. After going public in 2021, SomaLogic announced a merger with Standard BioTools in 2023.
Funding Status and Investment Opportunities
CU Boulder Programs
This page was last updated Nov. 13, 2023. Please contact us for corrections or updates